Sinopharm Group (HKG:1099) recorded net profit attributable to equity holders of the parent of 5.28 billion yuan for the nine months ended Sept. 30, lower than 6.10 billion yuan logged for the year-ago period, a Monday filing with the Hong Kong Exchange said.

The earnings per share stood at 1.69 yuan for the period, lower than 1.96 yuan per share recorded for the period last year.

The pharmaceutical company's total operating revenue for the nine months came in at 442.4 billion yuan, lower than 445.9 billion yuan from a year ago.

The company's shares were up over 1% in recent trade.

Price (HKD): $20.25, Change: $+0.27, Percent Change: +1.35%